These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36759298)

  • 1. Access to definitive treatment and survival for intermediate-risk and high-risk prostate cancer at hospital systems serving health disparity populations.
    Nguyen DD; Labban M; Briggs L; Wallis CJD; Cole AP; Lipsitz SR; Iyer HS; Rebbeck TR; Weissman JS; Choueiri TK; Trinh QD
    Urol Oncol; 2023 May; 41(5):252.e9-252.e17. PubMed ID: 36759298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of type of definitive treatment on race-based differences in prostate cancer-specific survival.
    Frego N; Labban M; Stone BV; Koelker M; Alkhatib K; Lughezzani G; Buffi NM; Lipsitz SR; Weissman JS; Fletcher SA; Kibel AS; Trinh QD; Cole AP
    Prostate; 2023 Aug; 83(11):1099-1111. PubMed ID: 37150867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Medicaid Expansion on Receipt of Definitive Treatment and Time to Treatment Initiation by Racial and Ethnic Minorities and at Minority-Serving Hospitals: A Patient-Level and Facility-Level Analysis of Breast, Colon, Lung, and Prostate Cancer.
    Nguyen DD; Paciotti M; Marchese M; Cole AP; Cone EB; Kibel AS; Ortega G; Lipsitz SR; Weissman JS; Trinh QD
    JCO Oncol Pract; 2021 May; 17(5):e654-e665. PubMed ID: 33974827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of Care in the Treatment of Localized Intermediate and High Risk Prostate Cancer at Minority Serving Hospitals.
    Krimphove MJ; Fletcher SA; Cole AP; Berg S; Sun M; Lipsitz SR; Mahal BA; Nguyen PL; Choueiri TK; Kibel AS; Kluth LA; Weissman JS; Trinh QD
    J Urol; 2019 Apr; 201(4):735-741. PubMed ID: 30414956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer.
    Mahal BA; Ziehr DR; Aizer AA; Hyatt AS; Sammon JD; Schmid M; Choueiri TK; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Lathan C; Kim SP; Trinh QD; Nguyen PL
    Urol Oncol; 2014 Nov; 32(8):1285-91. PubMed ID: 24846344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Care at Minority-Serving vs Non-Minority-Serving Hospitals With Use of Palliative Care Among Racial/Ethnic Minorities With Metastatic Cancer in the United States.
    Cole AP; Nguyen DD; Meirkhanov A; Golshan M; Melnitchouk N; Lipsitz SR; Kilbridge KL; Kibel AS; Cooper Z; Weissman J; Trinh QD
    JAMA Netw Open; 2019 Feb; 2(2):e187633. PubMed ID: 30707230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
    Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
    JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial differences in the treatment and outcomes for prostate cancer in Massachusetts.
    Cole AP; Herzog P; Iyer HS; Marchese M; Mahal BA; Lipsitz SR; Nyambose J; Gershman ST; Kennedy M; Merriam G; Rebbeck TR; Trinh QD
    Cancer; 2021 Aug; 127(15):2714-2723. PubMed ID: 33999405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient Characteristics at Prostate Cancer Diagnosis in Different Races at an Academic Center Serving a Diverse Population.
    Suresh T; Sharma J; Goel S; Kovac E; Gao Q; Gartrell B
    Clin Genitourin Cancer; 2019 Apr; 17(2):139-144. PubMed ID: 30655076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Income inequality and treatment of African American men with high-risk prostate cancer.
    Ziehr DR; Mahal BA; Aizer AA; Hyatt AS; Beard CJ; D Amico AV; Choueiri TK; Elfiky A; Lathan CS; Martin NE; Sweeney CJ; Trinh QD; Nguyen PL
    Urol Oncol; 2015 Jan; 33(1):18.e7-18.e13. PubMed ID: 25306287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delays in definitive cervical cancer treatment: An analysis of disparities and overall survival impact.
    Ramey SJ; Asher D; Kwon D; Ahmed AA; Wolfson AH; Yechieli R; Portelance L
    Gynecol Oncol; 2018 Apr; 149(1):53-62. PubMed ID: 29605051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer.
    Bagley AF; Anscher MS; Choi S; Frank SJ; Hoffman KE; Kuban DA; McGuire SE; Nguyen QN; Chapin B; Aparicio A; Pezzi TA; Smith GL; Smith BD; Hess K; Tang C
    JAMA Netw Open; 2020 Mar; 3(3):e201255. PubMed ID: 32191331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancer.
    Mahal BA; Ziehr DR; Aizer AA; Hyatt AS; Lago-Hernandez C; Choueiri TK; Elfiky AA; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Kim SP; Lathan CS; Trinh QD; Nguyen PL
    J Geriatr Oncol; 2014 Oct; 5(4):352-8. PubMed ID: 24862107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities in Diagnosis, Treatment Access, and Time to Treatment Among Hispanic Men With Metastatic Prostate Cancer.
    Hougen HY; Swami N; Dee EC; Alshalalfa M; Meiyappan K; Florez N; Penedo FJ; Nguyen PL; Punnen S; Mahal BA
    JCO Oncol Pract; 2023 Aug; 19(8):645-653. PubMed ID: 37262399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of treatment at minority-serving hospitals on outcomes for bladder cancer.
    Fletcher SA; Gild P; Cole AP; Vetterlein MW; Kibel AS; Choueiri TK; Sonpavde GP; Preston MA; Pucheril D; Menon M; Sun M; Lipsitz SR; Trinh QD
    Urol Oncol; 2018 May; 36(5):238.e7-238.e17. PubMed ID: 29454591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial disparities in treatment and outcomes between non-Hispanic Black and non-Hispanic White women with nonmetastatic inflammatory breast cancer.
    Carbajal-Ochoa WH; Johnson D; Alvarez A; Bernal AM; Anampa JD
    Breast Cancer Res Treat; 2023 Sep; 201(2):275-287. PubMed ID: 37442877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Undertreatment of High-Risk Localized Prostate Cancer in the California Latino Population.
    Lichtensztajn DY; Leppert JT; Brooks JD; Shah SA; Sieh W; Chung BI; Gomez SL; Cheng I
    J Natl Compr Canc Netw; 2018 Nov; 16(11):1353-1360. PubMed ID: 30442735
    [No Abstract]   [Full Text] [Related]  

  • 18. Racial differences in patient-reported outcomes among men treated with radical prostatectomy for prostate cancer.
    Koelker M; Labban M; Frego N; Ye J; Lipsitz SR; Hubbell HT; Edelen M; Steele G; Salinas K; Meyer CP; Makanjuola J; Moore CM; Cole AP; Kibel AS; Trinh QD
    Prostate; 2024 Jan; 84(1):47-55. PubMed ID: 37710385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparities in Hispanic/Latino and non-Hispanic Black men with low-risk prostate cancer and eligible for active surveillance: a population-based study.
    Katz JE; Chinea FM; Patel VN; Balise RR; Venkatramani V; Gonzalgo ML; Ritch C; Pollack A; Parekh DJ; Punnen S
    Prostate Cancer Prostatic Dis; 2018 Nov; 21(4):533-538. PubMed ID: 29988097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial Disparities in Health Care Resource Utilization After Pediatric Cervical and/or Thoracic Spinal Injuries.
    Elsamadicy AA; Sandhu MR; Freedman IG; Koo AB; Hengartner AC; Reeves BC; Havlik J; Sarkozy M; Hong CS; Kundishora AJ; Tuason DA; DiLuna M
    World Neurosurg; 2021 Dec; 156():e307-e318. PubMed ID: 34560297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.